{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:10:16Z","timestamp":1788966616022,"version":"build-2803163510"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background and purpose:<\/jats:title>\n                    <jats:p>Glioblastoma (GBM) is an aggressive brain tumor with limited treatment options and poor patient survival. This study aimed to identify key genes and altered pathways in GBM and to explore potential drug-repurposing candidates using a systems biology approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental approach:<\/jats:title>\n                    <jats:p>We analyzed gene expression data from two public datasets (GSE4290 and GSE50161) using Transcriptome Analysis Console. These datasets included 102 GBM samples and 23 non-tumor brain samples. We identified differentially expressed genes using statistical thresholds. A protein-protein interaction network was built using STRING and analyzed in Cytoscape based on degree, betweenness, and closeness metrics. Pathway analysis was carried out using KEGG. Survival analysis was performed with GEPIA2. Drug-gene interactions were screened using DGIdb, and molecular docking was carried out for selected targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings\/Results:<\/jats:title>\n                    <jats:p>A total of 1,704 upregulated and 1,345 downregulated genes were detected. Network analysis highlighted TP53, EGFR, CDC42, and STAT3 as central hub genes. Pathway analysis showed major changes in MAPK signaling, neuroactive ligand-receptor interaction, and extracellular matrix-receptor interaction. Higher expression of CDC42, EGFR, and TP53 was associated with shorter overall survival in GBM patients. Drug screening identified 28 approved compounds targeting six core genes. Docking analysis showed strong binding affinity for several candidates, with scores of -8.5 kcal\/mol or lower.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and implications:<\/jats:title>\n                    <jats:p>This study identified important molecular targets and pathways in GBM and suggests several existing drugs with potential value for therapeutic repurposing. These findings may support future experimental and clinical studies in GBM treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/rps.rps_193_25","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:18:37Z","timestamp":1788949117000},"page":"682-701","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Systems biology-driven drug repurposing in glioblastoma via antigen and pathway mapping"],"prefix":"10.4103","volume":"21","author":[{"given":"Erfan","family":"Zaker","sequence":"first","affiliation":[{"name":"Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Nouri","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parsa","family":"Pashangeh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Novel Drug Delivery Systems Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid Razavi","family":"Dizaji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahim","family":"Asghari","sequence":"additional","affiliation":[{"name":"Hematology, Immune Cell Therapy, and Stem Cells Transplantation Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar","family":"Davoodi","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Computer Science, University of Southern Denmark, 5230 Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilnaz","family":"Rahimmanesh","sequence":"additional","affiliation":[{"name":"Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"R1-20260909","doi-asserted-by":"crossref","first-page":"1887815,1","DOI":"10.3389\/fimmu.2026.1887815","article-title":"Long non-coding RNAs in glioblastoma: from molecular drivers to therapeutic targets","volume":"17","author":"Elemam","year":"2026","journal-title":"Front Immunol"},{"issue":"Suppl 2","key":"R2-20260909","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/neuonc\/not151","article-title":"CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010","volume":"15","author":"Ostrom","year":"2013","journal-title":"Neuro Oncol"},{"issue":"10","key":"R3-20260909","doi-asserted-by":"crossref","first-page":"2412,1","DOI":"10.3390\/cancers14102412","article-title":"Epidemiology of glioblastoma multiforme-literature review","volume":"14","author":"Grochans","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"R4-20260909","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ng.408","article-title":"Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility","volume":"41","author":"Wrensch","year":"2009","journal-title":"Nat Genet"},{"key":"R5-20260909","doi-asserted-by":"crossref","first-page":"1364138,1","DOI":"10.3389\/fphar.2024.1364138","article-title":"System biology approach to identify the novel biomarkers in glioblastoma multiforme tumors by using computational analysis","volume":"15","author":"Alqahtani","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"R6-20260909","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12539-016-0185-4","article-title":"LPRP: a gene-gene interaction network construction algorithm and its application in breast cancer data analysis","volume":"10","author":"Su","year":"2018","journal-title":"Interdiscip Sci"},{"key":"R7-20260909","doi-asserted-by":"crossref","first-page":"1175844,1","DOI":"10.3389\/fmicb.2023.1175844","article-title":"Discovering common pathogenic processes between COVID-19 and HFRS by integrating RNA-seq differential expression analysis with machine learning","volume":"14","author":"Noor","year":"2023","journal-title":"Front Microbiol"},{"issue":"2","key":"R8-20260909","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12539-020-00360-0","article-title":"An integrated systems biology and network-based approaches to identify novel biomarkers in breast cancer cell lines using gene expression data","volume":"12","author":"Khan","year":"2020","journal-title":"Interdiscip Sci"},{"issue":"11","key":"R9-20260909","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1080\/07391102.2024.2308756","article-title":"Network pharmacology and molecular dynamic simulation integrated strategy for the screening of active components and mechanisms of phytochemicals from Datura innoxia on Alzheimer and cognitive decline","volume":"43","author":"Alamri","year":"2025","journal-title":"J Biomol Struct Dyn"},{"issue":"23","key":"R10-20260909","doi-asserted-by":"crossref","first-page":"12654,1","DOI":"10.3390\/ijms222312654","article-title":"Blood-brain barrier in brain tumors: biology and clinical relevance","volume":"22","author":"Mo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R11-20260909","doi-asserted-by":"crossref","first-page":"419,1","DOI":"10.3389\/fonc.2018.00419","article-title":"A critical overview of targeted therapies for glioblastoma","volume":"8","author":"Jain","year":"2018","journal-title":"Front Oncol"},{"issue":"3","key":"R12-20260909","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/pr.117.014944","article-title":"Current challenges and opportunities in treating glioblastoma","volume":"70","author":"Shergalis","year":"2018","journal-title":"Pharmacol Rev"},{"issue":"8","key":"R13-20260909","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/neuonc\/nov031","article-title":"Toward precision medicine in glioblastoma: the promise and the challenges","volume":"17","author":"Prados","year":"2015","journal-title":"Neuro Oncol"},{"issue":"4","key":"R14-20260909","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2006.03.003","article-title":"Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain","volume":"9","author":"Sun","year":"2006","journal-title":"Cancer Cell"},{"issue":"9","key":"R15-20260909","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.4049\/jimmunol.1301966","article-title":"Characterization of distinct immunophenotypes across pediatric brain tumor types","volume":"191","author":"Griesinger","year":"2013","journal-title":"J Immunol"},{"issue":"Database issue","key":"R16-20260909","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10:protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"R17-20260909","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape:a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"5","key":"R18-20260909","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/bioinformatics\/btt019","article-title":"CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data","volume":"29","author":"Bindea","year":"2013","journal-title":"Bioinformatics"},{"key":"R19-20260909","doi-asserted-by":"crossref","first-page":"2,1","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinformatics"},{"issue":"Suppl 4","key":"R20-20260909","first-page":"S11,1","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"issue":"3","key":"R21-20260909","first-page":"100141,1","article-title":"clusterProfiler 4.0:a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"issue":"W1","key":"R22-20260909","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"R23-20260909","doi-asserted-by":"crossref","first-page":"D1068","DOI":"10.1093\/nar\/gkx1143","article-title":"DGIdb 3.0:a redesign and expansion of the drug-gene interaction database","volume":"46","author":"Cotto","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"R24-20260909","doi-asserted-by":"crossref","first-page":"17,1","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J Cheminform"},{"key":"R25-20260909","first-page":"33,1","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J Cheminform"},{"key":"R26-20260909","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"11","key":"R27-20260909","doi-asserted-by":"crossref","first-page":"e4792,1","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX:tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci"},{"issue":"2","key":"R28-20260909","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"8","key":"R29-20260909","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0:new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J Chem Inf Model"},{"issue":"7471","key":"R30-20260909","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"2","key":"R31-20260909","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc3430","article-title":"MDM2, MDMX and p53 in oncogenesis and cancer therapy","volume":"13","author":"Wade","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"R32-20260909","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s11033-024-09996-3","article-title":"Harnessing the role of aberrant cell signaling pathways in glioblastoma multiforme:a prospect towards the targeted therapy","volume":"51","author":"Hasan","year":"2024","journal-title":"Mol Biol Rep"},{"key":"R33-20260909","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.biopha.2017.05.125","article-title":"Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy:a review","volume":"92","author":"Anjum","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"R34-20260909","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yexmp.2018.05.009","article-title":"Intratumor MAPK and PI3K signaling pathway heterogeneity in glioblastoma tissue correlates with CREB signaling and distinct target gene signatures","volume":"105","author":"Daniel","year":"2018","journal-title":"Exp Mol Pathol"},{"issue":"11","key":"R35-20260909","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00018-011-0898-9","article-title":"MAPK pathway activation in pilocytic astrocytoma","volume":"69","author":"Jones","year":"2012","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"R36-20260909","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4155\/fmc-2018-0468","article-title":"MAPK pathway:a potential target for the treatment of non-small-cell lung carcinoma","volume":"11","author":"Pradhan","year":"2019","journal-title":"Future Med Chem"},{"issue":"1","key":"R37-20260909","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1021\/acschemneuro.7b00168","article-title":"Augmenting glioblastoma chemotherapy with polymers","volume":"9","author":"Skinner","year":"2018","journal-title":"ACS Chem Neurosci"},{"issue":"35","key":"R38-20260909","doi-asserted-by":"crossref","first-page":"56958","DOI":"10.18632\/oncotarget.10925","article-title":"A role for activated Cdc42 in glioblastoma multiforme invasion","volume":"7","author":"Okura","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"R39-20260909","doi-asserted-by":"crossref","first-page":"2316,1","DOI":"10.3390\/ijms25042316","article-title":"Epidermal growth factor receptor inhibitors in glioblastoma: current status and future possibilities","volume":"25","author":"Ezzati","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"R40-20260909","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.celrep.2017.10.030","article-title":"Single-cell RNA-seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma","volume":"21","author":"Darmanis","year":"2017","journal-title":"Cell Rep"},{"issue":"24","key":"R41-20260909","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1080\/15384101.2018.1557496","article-title":"Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling","volume":"17","author":"Shahid","year":"2018","journal-title":"Cell Cycle"},{"issue":"11","key":"R42-20260909","doi-asserted-by":"crossref","first-page":"e1900038,1","DOI":"10.1002\/pmic.201900038","article-title":"Downregulation of CENPF remodels prostate cancer cells and alters cellular metabolism","volume":"19","author":"Shahid","year":"2019","journal-title":"proteomics"},{"issue":"7","key":"R43-20260909","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/cas.14037","article-title":"Lymphoid-specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression","volume":"110","author":"Yang","year":"2019","journal-title":"Cancer Sci"},{"issue":"3","key":"R44-20260909","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3934\/mbe.2021107","article-title":"Transcriptome analysis revealed CENPF associated with glioma prognosis","volume":"18","author":"Zhang","year":"2021","journal-title":"Math Biosci Eng"},{"issue":"16","key":"R45-20260909","doi-asserted-by":"crossref","first-page":"3970,1","DOI":"10.3390\/cancers14163970","article-title":"Neurotransmitters: potential targets in Glioblastoma","volume":"14","author":"Huang","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"R46-20260909","first-page":"24","article-title":"The role of the nervous system in the development of brain tumorigenesis: from neurons to the tumor microenvironment","volume":"1","author":"Xue","year":"2025","journal-title":"Clin Res Oncol"},{"issue":"1","key":"R47-20260909","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"R48-20260909","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4103\/RPS.RPS_52_24","article-title":"Exploring the diagnostic and prognostic potential of LCFAs\u2019 metabolic and biosynthetic pathways in glioblastoma multiforme using a bioinformatics approach","volume":"20","author":"Heydarian","year":"2025","journal-title":"Res Pharm Sci"},{"key":"R49-20260909","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia"},{"key":"R50-20260909","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.2147\/DDDT.S106196","article-title":"Understanding cytoskeleton regulators in glioblastoma multiforme for therapy design","volume":"10","author":"Masoumi","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"R51-20260909","doi-asserted-by":"crossref","first-page":"120488","DOI":"10.1016\/j.jns.2022.120488","article-title":"Altered glutamatergic and inflammatory pathways promote glioblastoma growth, invasion, and seizures: an overview","volume":"443","author":"Feyissa","year":"2022","journal-title":"J Neurol Sci"},{"issue":"24","key":"R52-20260909","doi-asserted-by":"crossref","first-page":"17633,1","DOI":"10.3390\/ijms242417633","article-title":"Role of glycolytic and glutamine metabolism reprogramming on the proliferation, invasion, and apoptosis resistance through modulation of signaling pathways in glioblastoma","volume":"24","author":"Trejo-Sol\u00eds","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"R53-20260909","first-page":"1","article-title":"The impact of brain tumors on emotional and behavioral functioning","volume":"16","author":"Samman","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"R54-20260909","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/RPS.RPS_171_23","article-title":"A bioinformatics approach of specificity protein transcription factors in head and neck squamous cell carcinoma","volume":"19","author":"Sichani","year":"2024","journal-title":"Res Pharm Sci"},{"issue":"1","key":"R55-20260909","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol Rev"},{"key":"R56-20260909","doi-asserted-by":"crossref","first-page":"1192766,1","DOI":"10.3389\/fnins.2023.1192766","article-title":"CDC42-A promising immune-related target in glioma","volume":"17","author":"Jiang","year":"2023","journal-title":"Front Neurosci"},{"issue":"26","key":"R57-20260909","doi-asserted-by":"crossref","first-page":"22531","DOI":"10.1021\/acsomega.2c01820","article-title":"Integrated transcriptome profiling identifies prognostic hub genes as therapeutic targets of glioblastoma: evidenced by bioinformatics analysis","volume":"7","author":"Nayak","year":"2022","journal-title":"ACS Omega"},{"issue":"21","key":"R58-20260909","doi-asserted-by":"crossref","first-page":"5227,1","DOI":"10.3390\/cancers14215227","article-title":"Pleiotropy of PP2A phosphatases in cancer with a focus on glioblastoma IDH wildtype","volume":"14","author":"Kashani","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"R59-20260909","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41401-020-0418-2","article-title":"Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"R60-20260909","doi-asserted-by":"crossref","first-page":"2411,1","DOI":"10.3390\/ijms24032411","article-title":"Ca2+-dependent effects of the selenium-sorafenib nanocomplex on glioblastoma cells and astrocytes of the cerebral cortex: anticancer agent and cytoprotector","volume":"24","author":"Varlamova","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"R61-20260909","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1227\/01.NEU.0000145865.25689.55","article-title":"Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo","volume":"56","author":"Eller","year":"2005","journal-title":"Neurosurgery"},{"issue":"11","key":"R62-20260909","doi-asserted-by":"crossref","first-page":"5694,1","DOI":"10.3390\/ijms25115694","article-title":"Advances in anti-cancer drug development: metformin as anti-angiogenic supplemental treatment for glioblastoma","volume":"25","author":"Shah","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"20","key":"R63-20260909","doi-asserted-by":"crossref","first-page":"e70288,1","DOI":"10.1002\/cam4.70288","article-title":"New anti-angiogenic therapy for glioblastoma with the anti-depressant sertraline","volume":"13","author":"Tsuboi","year":"2024","journal-title":"Cancer Med"},{"issue":"4","key":"R64-20260909","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4103\/RPS.RPS_148_24","article-title":"In silico prediction of paradoxical effect for oxaliplatin in gastric cancer patients based on their transcriptomic profile","volume":"20","author":"Khara","year":"2025","journal-title":"Res Pharm Sci"},{"issue":"1","key":"R65-20260909","doi-asserted-by":"crossref","first-page":"138,1","DOI":"10.1186\/s12894-024-01521-9","article-title":"In silico exploration of anti-prostate cancer compounds from differential expressed genes","volume":"24","author":"Ajiboye","year":"2024","journal-title":"BMC Urol"},{"key":"R66-20260909","doi-asserted-by":"crossref","first-page":"245,1","DOI":"10.25259\/SNI_818_2024","article-title":"Dexamethasone-associated regression of glioblastoma","volume":"16","author":"Segura Arderiu","year":"2025","journal-title":"Surg Neurol Int"}],"container-title":["Research in Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/RPS.RPS_193_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:15:45Z","timestamp":1788963345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/RPS.RPS_193_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/rps.rps_193_25","relation":{},"ISSN":["1735-5362","1735-9414"],"issn-type":[{"value":"1735-5362","type":"print"},{"value":"1735-9414","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2025-10-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}